Collegium Pharmaceutical, Inc. COLL Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s treasury stock?
- Collegium Pharmaceutical, Inc. (COLL) reported treasury stock of $222.51M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s treasury stock changed year-over-year?
- Collegium Pharmaceutical, Inc.'s treasury stock increased by 12.7% year-over-year, from $197.51M to $222.51M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s treasury stock?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s treasury stock has grown at a 50.9% compound annual growth rate (CAGR), from $42.86M to $222.51M.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.